Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
03/2009
03/19/2009CA2698912A1 Use of a peptide as a therapeutic agent
03/19/2009CA2698855A1 Use of a peptide as a therapeutic agent
03/19/2009CA2698852A1 Use of a peptide as a therapeutic agent
03/19/2009CA2698833A1 Use of a peptide as a therapeutic agent
03/19/2009CA2698831A1 Use of a peptide as a therapeutic agent
03/19/2009CA2698828A1 Use of a peptide as a therapeutic agent
03/19/2009CA2698824A1 Use of peptide yy, alone or in combination with glucagon-like peptide, for use in medicine
03/19/2009CA2698822A1 Minigastrin as a therapeutic agent
03/19/2009CA2698821A1 Use of a peptide as a therapeutic agent
03/19/2009CA2698819A1 6-pyrimidinyl-pyrimid-2-one derivative
03/19/2009CA2698818A1 3-methyl-2- ( (2s) -2- (4- (3-methyl-1, 2, 4-oxadiazol-5-yl) phenyl) morpholino) -6- (pyrimidin-4-yl) pyrimidin-4 (3h) -one as tau protein kinase inhibitor
03/19/2009CA2698786A1 Use of a peptide as a therapeutic agent
03/19/2009CA2698783A1 Use of a peptide as a therapeutic agent
03/19/2009CA2698778A1 Use of a peptide as a therapeutic agent
03/19/2009CA2698770A1 Use of secretin and optionally urodilatin as a therapeutic agents
03/19/2009CA2698759A1 Use of a peptide as a therapeutic agent
03/19/2009CA2698754A1 Use of a peptide as a therapeutic agent
03/19/2009CA2698748A1 Use of a peptide as a therapeutic agent
03/19/2009CA2698745A1 Use of a peptide as a therapeutic agent
03/19/2009CA2698693A1 Use of a peptide as a therapeutic agent
03/19/2009CA2698691A1 Use of a peptide as a therapeutic agent
03/19/2009CA2698682A1 Use of a peptide as a therapeutic agent
03/19/2009CA2698666A1 Use of a peptide as a therapeutic agent
03/19/2009CA2698371A1 Alkylsulfone derivatives
03/19/2009CA2697399A1 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones
03/19/2009CA2696948A1 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h,1'h-[1,4']bipyridinyl-2'-ones
03/19/2009CA2691782A1 Octahydro-pyrrolo[3,4-b]pyrrole n-oxides
03/18/2009EP2036926A2 Single-chain, multiple antigen forming molecule, its manufacture and use
03/18/2009EP2036918A1 Peptide derivative
03/18/2009EP2036909A1 Quaternary ammonium salt compounds of spirocyclopiperazines, preparation methods and uses thereof
03/18/2009EP2036905A1 Pyridylisoxazole derivative
03/18/2009EP2036902A2 Urea compounds active as vanilloid receptor antagonist for the treatment of pain
03/18/2009EP2036895A1 Hsp90 inhibitor
03/18/2009EP2036891A2 Isoquinoline inhibitors of P38
03/18/2009EP2036888A1 Naphthyl-substituted sulfonamides
03/18/2009EP2036887A1 Novel 6-5 bicycic heterocyclic derivative and medical use thereof
03/18/2009EP2036566A1 Use of 20(s)-protopanoxadiol in manufacture of antidepressants
03/18/2009EP2036564A1 The combination of a serotonin reuptake inhibitor and a 5-HT2C antagonist, inverse agonist or partial agonist
03/18/2009EP2036563A1 Use of dihydroimidazolones for the treatment of behavioural abnormalities in dogs
03/18/2009EP2036559A1 Novel tape preparation
03/18/2009EP2036558A2 Orally administrable opioid formulations having extended duration of effect
03/18/2009EP2036553A1 Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment, modification and management of pain
03/18/2009EP2036547A2 Treatment for Attention-Deficit Hyperactivity Disorder
03/18/2009EP2036540A2 Improved injectable dispersions of propofol
03/18/2009EP2035575A2 Methods of treatment
03/18/2009EP2035429A1 FUSED [d]PYRIDAZIN-7-ONES
03/18/2009EP2035427A2 Pyrazolo[1,5-a]pyrimidine compounds as cb1 receptor antagonist
03/18/2009EP2035425A1 Amino- imidazolones and their use as a medicament for treating cognitive impairment, alzheimer disease, neurodegeneration and dementia.
03/18/2009EP2035424A1 Amino-imidazolones and their use as a medicament for treating cognitive impairment, alzheimer disease, neurodegeneration and dementia.
03/18/2009EP2035423A1 Amino-imidazolones and their use as a medicament for treating cognitive impairment, alzheimer disease, neurodegeneration and dementia
03/18/2009EP2035421A1 2-ARYLPYRAZOLO[L,5-alpha]PYRIMIDIN-3-YL ACETAMIDE DERIVATIVES AS LIGANDS FOR TRANSLOCATOR PROTEIN (18 KDA)
03/18/2009EP2035418A1 Novel heteroaryl substituted benzoxazoles
03/18/2009EP2035412A1 Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia
03/18/2009EP2035411A1 Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia.
03/18/2009EP2035409A1 Benzimidazole derivatives which are to be used as anatgonist for the cb1-receptor
03/18/2009EP2035407A1 Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia
03/18/2009EP2035406A1 Novel substituted-1h-quinazoline-2,4-dione derivatives, preparation method thereof and pharmaceutical composition containing the same
03/18/2009EP2035404A1 Crystalline duloxetine hydrochloride
03/18/2009EP2035403A1 Crystalline duloxetine hydrochloride
03/18/2009EP2035394A1 2-pyrazinecarboxamide derivatives
03/18/2009EP2035389A1 Therapeutic agents
03/18/2009EP2035388A1 Therapeutic agents
03/18/2009EP2035378A1 Substituted isoindoles as bace inhibitors and their use
03/18/2009EP2035373A1 Phenyl pyrrole aminoguanidine derivatives
03/18/2009EP2035370A2 Tetralin and indane derivatives and uses thereof
03/18/2009EP2035029A2 Peptide compounds for treating refractory status epilepticus
03/18/2009EP2035026A2 A synergistic herbal composition from bacopa species for management of neurodegenerative disorders and a process of preparation thereof
03/18/2009EP2035025A1 Use of extracts or extractants of the guajacum types, said extracts or extractants bringing about phosphodiesterase-4 inhibition and method for producing the same
03/18/2009EP2035003A1 A method of reducing amyloid-beta peptide levels using a bisdioxopiperazine
03/18/2009EP2034989A2 Methods and compositions for improving cognitive function
03/18/2009EP2034988A2 Compositions and kits comprising a melatonin component and a flavanol component
03/18/2009EP2034987A1 New use for cannabinoid
03/18/2009EP2034982A1 Composition for foodstuff for binding acetaldehyde
03/18/2009EP2034839A2 Treatment of neurodegenerative diseases through inhibiton of hsp90
03/18/2009EP2034838A2 Novel compounds
03/18/2009EP1940376B1 Use of neboglamine in the treatment of toxicodependency
03/18/2009EP1824486B1 Benzdioxane piperazine derivatives with a combination of affinity for dopamine-d2 receptors and serotonin reuptake sites
03/18/2009EP1805129B1 (biphenyl) carboxylic acids and derivatives thereof
03/18/2009EP1678498B1 Method for determining the antiradical defense potential and use thereof, in particular in veterinary and human preventive therapeutics
03/18/2009EP1613328B1 Use of carbamazepine derivatives for the treatment of agitation in dementia patients
03/18/2009EP1575960B1 1,4-diazabicyclo 3.2.2 nonanecarboxamide derivatives, preparation and therapeutic use thereof
03/18/2009EP1546103B1 Piperazine and piperidine derivatives for treatment of neurological diseases
03/18/2009EP1513806B1 Sulphonic acid salts of mandelic acid derivatives
03/18/2009EP1389096B1 Delivery of opioids through an inhalation route
03/18/2009EP1386912B1 Cyclic amidine derivative
03/18/2009EP1292294B1 Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease
03/18/2009EP1095136B1 Cells and animals deficient in protein kinase c epsilon
03/18/2009EP0963984B1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics
03/18/2009EP0741783B1 Vertebrate embryonic pattern-inducing hedgehog-like proteins
03/18/2009CN101389626A Fused ring heterocycle kinase modulators
03/18/2009CN101389623A New salts of an indole derivative and their use in medicine
03/18/2009CN101389608A 5-HT7 receptor antagonists
03/18/2009CN101389600A Optical isomers of dihydro-2,3-benzodiazepine derivatives, process for their stereoselective synthesis
03/18/2009CN101389325A Treatment of drug abuse
03/18/2009CN101386818A Extract of sea fungal culture and preparation method and application thereof
03/18/2009CN101386623A Preparation of 1-aza-2-oxa-dibenzo[e,h]azulenes and their medical use
03/18/2009CN101385859A Glutathione based delivery system
03/18/2009CN101385815A Traditional Chinese medicine for treating dementia after stroke
03/18/2009CN101385808A Quality control method of Zhubai tranquilizing pill
03/18/2009CN101385796A New use of Qingkailing in improving cognition dysfunction and preventing and treating senile dementia
1 ... 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 ... 1833